Urwyler, Stephan
Novartis International AG,
Switzerland
2025 Rank: 270,192
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 2,661 out of 157,499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 270,192 | 276,462 |
| Total Cites | 2,232 | 2,590 |
| H-index | 20 | 23 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 217 | 219 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 736 | 838 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 1,009 | 1,134 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,831 | 2,063 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.26 |
| Self-Citation Percentage |
13.82%
|
|
Urwyler, Stephan
Novartis International AG,
Switzerland
2024 Rank: 267,606
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 2,687 out of 148,458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 267,606 | 267,218 |
| Total Cites | 2,178 | 2,536 |
| H-index | 19 | 22 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 204 | 206 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 708 | 809 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 974 | 1,098 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,791 | 2,025 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.25 |
| Self-Citation Percentage |
14.12%
|
|
Urwyler, Stephan
Novartis International AG,
Switzerland
2023 Rank: 251,082
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 2,564 out of 140,593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 251,082 | 249,920 |
| Total Cites | 2,147 | 2,504 |
| H-index | 19 | 22 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 199 | 201 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 695 | 796 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 956 | 1,080 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,764 | 1,997 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.25 |
| Self-Citation Percentage |
14.26%
|
|
Urwyler, Stephan
Novartis International AG,
Switzerland
2022 Rank: 232,023
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 2,383 out of 134,745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 232,023 | 235,401 |
| Total Cites | 2,088 | 2,442 |
| H-index | 20 | 22 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 181 | 183 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 659 | 759 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 906 | 1,029 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,724 | 1,955 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.25 |
| Self-Citation Percentage |
14.50%
|
|
Urwyler, Stephan
Novartis International AG,
Switzerland
2021 Rank: 234,460
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 2,466 out of 131,063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 234,460 | 242,156 |
| Total Cites | 2,053 | 2,399 |
| H-index | 19 | 21 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 172 | 174 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 643 | 743 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 887 | 1,010 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,696 | 1,919 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.25 |
| Self-Citation Percentage |
14.42%
|
|
Urwyler, Stephan
Novartis International AG,
Switzerland
2020 Rank: 221,011
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 1,215 out of 80,622 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 221,011 | 225,128 |
| Total Cites | 1,990 | 2,330 |
| H-index | 19 | 21 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 153 | 155 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 608 | 707 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 847 | 969 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,646 | 1,866 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.25 |
| Self-Citation Percentage |
14.59%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.